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ORIGINAL ARTICLE
Autism spectrum disorders and autistic traits share genetics
and biology
J Bralten1,2, KJ van Hulzen1, MB Martens3, TE Galesloot4, A Arias Vasquez1,2,5,6, LA Kiemeney4, JK Buitelaar5,7, JW Muntjewerff6,
B Franke1,2,6,9 and G Poelmans1,8,9
Autism spectrum disorders (ASDs) and autistic traits in the general population may share genetic susceptibility factors. In this study,
we investigated such potential overlap based on common genetic variants. We developed and validated a self-report questionnaire
of autistic traits in adults. We then conducted genome-wide association studies (GWASs) of six trait scores derived from the
questionnaire through exploratory factor analysis in 1981 adults from the general population. Using the results from the Psychiatric
Genomics Consortium GWAS of ASDs, we observed genetic sharing between ASDs and the autistic traits 'childhood behavior',
'rigidity' and 'attention to detail'. Gene-set analysis subsequently identiﬁed 'rigidity' to be signiﬁcantly associated with a network of
ASD gene-encoded proteins that regulates neurite outgrowth. Gene-wide association with the well-established ASD gene MET
reached signiﬁcance. Taken together, our ﬁndings provide evidence for an overlapping genetic and biological etiology underlying
ASDs and autistic population traits, which suggests that genetic studies in the general population may yield novel ASD genes.
Molecular Psychiatry (2018) 23, 1205–1212; doi:10.1038/mp.2017.98; published online 16 May 2017
INTRODUCTION
Autism spectrum disorders (ASDs) are a group of pervasive
neurodevelopmental disorders that are characterized by impair-
ments in reciprocal social interaction and communication, as well
as restricted, repetitive and stereotyped patterns of behavior,
interests and activities.1 The prevalence of ASDs in the general
population is estimated to be ~ 1%,2 with approximately four
times more males than females being affected by these
disorders.3,4 Family and twin studies show that ASDs are highly
heritable, and ~ 65–90% of the phenotypic variance can be
explained by genetic factors.4–7 Despite this considerable herit-
ability, the identiﬁcation and replication of genetic susceptibility
factors for ASDs has been challenging, as their genetic architec-
ture is complex and highly heterogeneous, with both common
and rare inherited, as well as de novo genetic variants contributing
to ASD etiology.8,9 In 2013, molecular landscape analysis by our
research group, combining evidence from genome-wide assoctia-
tion studies (GWASs) of ASDs, rare genetic variant studies (exome-
sequencing and copy number variation studies) and other genetic
evidence (candidate gene association, microRNA and gene
expression, gene function and animal studies), showed that
available genetic data for ASDs converge on protein networks
regulating three biological processes, namely steroidogenesis,
neurite outgrowth and (glutamatergic) synaptic function.10
Autistic traits can be deﬁned as subthreshold deﬁcits in social
interaction and communication, as well as restricted behaviors,
interests and activities that are continuously distributed in the
general population.11
Population-based twin studies have shown that, like ASDs, such
autistic traits are heritable, with heritability rates ranging from 36
to 87%.12,13 There is ample evidence suggesting that ASDs
represent the upper extreme on the continuous distribution of
these autistic traits in the population.11,14–18 Indeed, a twin study
showed that autistic population traits and ASDs share genetic
susceptibility factors.18 Furthermore, in a recent study, Robinson
et al.19 used large genomic data sets to demonstrate that there is a
genetic correlation between certain autistic traits—that is, social
and communication skill impairments assessed in children from
the general population—and ASDs.
The above evidence suggests that genetic studies of autistic
traits in the general population could not only provide corrobor-
ating evidence for the involvement of previously identiﬁed ASD
candidate genes—as shown in two previous studies20,21—but
may also aid in the identiﬁcation of novel ASD susceptibility genes
and loci. This could substantially ease research efforts to increase
our understanding of the biology underlying ASDs. To measure
autistic traits in the general population, a number of ques-
tionnaires have been developed, and of those, the Autism
Spectrum Quotient (AQ) and the Social and Communication
Disorders Checklist (SCDC) are commonly used in genetic studies.
The AQ is a 50-item self-report questionnaire of autistic traits in
adults,22,23 the SCDC is a parent-rated questionnaire measuring
social communication impairment in children.24,25
In this article, we have further investigated the genetic overlap
between ASDs and autistic traits. To this end, we ﬁrst developed
and validated a questionnaire of autistic traits, suitable for use in
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population studies. In comparison with the AQ and SCDC, our
novel questionnaire captures more ASD-related features, is shorter
and less theory-based. In data of 1981 adults from the Dutch
general population, we then conducted GWASs of the scores for
six traits, that is, the scores for ‘total autistic traits’ from our
questionnaire as well as its ﬁve best-ﬁtting constituting factors:
‘childhood behavior’, ‘rigidity’, ’social skills’, ‘attention to detail’
and ‘imagination’. Through polygenic risk score-based analysis, we
observed overlap between genetic variants associated with ASDs
and several of these autistic traits. Subsequent gene-set analysis
identiﬁed 'rigidity' to be signiﬁcantly associated with the network
of ASD gene-encoded proteins that regulates neurite outgrowth
(see above). In addition, the MET gene was gene-wide signiﬁcantly
associated with this trait.
MATERIALS AND METHODS
Development and validation of a questionnaire of autistic traits in
adults
Based on the extensive clinical experience of authors JKB and JWM in
diagnosing and treating children and adults with ASDs, we constructed a
self-report questionnaire of autistic traits that consists of 18 questions/
items and could be administered to healthy adults. The 18 items in the
questionnaire were chosen because they comprehensively cover the three
main ASD symptom clusters, that is, deﬁcits in social interaction, deﬁcits in
communication and restricted behavior, interests and activities. In
addition, some items in the questionnaire do not assess current behaviors
but behaviors that occurred in childhood, and these items were included
because the concept of ASDs as early onset neurodevelopmental disorders
speciﬁes the onset of symptoms in childhood. Six items are based on the
Diagnostic and Statistical Manual of Mental Disorders, 4th Edition section
about ASDs1 and 12 items are extracted from the AQ. The AQ is a self-
report questionnaire of 50 items that was developed and validated for the
purpose of quantifying ASD-related traits in adult individuals with normal
intelligence in the general population.22 The AQ has been translated into
the Dutch language and validated in the Dutch general population and in
Dutch people with ASDs.23 Table 1 shows the 18 individual items of our
self-report questionnaire and it is indicated which items were taken or
derived from the AQ and the Diagnostic and Statistical Manual of Mental
Disorders, 4th Edition section about ASDs, respectively. For each item, the
respondents are asked to indicate on a 4-point likert scale how well that
statement applies to them, with the possible answer categories
‘1 =deﬁnitely agree’, ‘2 =partially agree’, ‘3 = partially disagree’ and
‘4 =deﬁnitely disagree’. The scoring is reversed for items in which an
‘agree’ response is characteristic for ASDs, and the item scores are then
summed, resulting in a minimum score of 18 (no autistic traits) and a
maximum score of 72 (full endorsement of all autistic traits).
To validate our questionnaire in terms of its ability to differentiate
between people with less and more autistic traits within the general
population, we ﬁrst administered the questionnaire to a Dutch general
population sample of 50 healthy adults as well as 24 Dutch adults that had
been diagnosed with an ASD by an experienced psychiatrist. We used a
T-test to quantify the difference between the means of the ‘total autistic
traits’ scores in the healthy adult and adult ASD patient samples.
Furthermore, we determined the correlation between the total scores on
our novel questionnaire and the total scores on the already established AQ
through also administering the complete AQ of 50 items to the same 50
Dutch general population respondents that answered our novel ques-
tionnaire. We used the corrcoef function in MATLAB (The Mathworks,
Natick, MA, USA) to calculate the correlation statistics.
Measuring autistic traits in the Dutch general population and
factor analysis of the questionnaire scores
After the validation step, our novel questionnaire was sent to participants
from the Nijmegen Biomedical Study (NBS), a population-based survey
conducted by the Department for Health Evidence and the Department of
Laboratory Medicine of the Radboud University Medical Center.26 Approval
to conduct the NBS was obtained from the Radboud University Medical
Center Institutional Review Board (CMO 2001/055). All participants gave
written informed consent.
Within the ﬁrst wave of NBS 22 451 age- and sex-stratiﬁed randomly
selected inhabitants of the municipality of Nijmegen received an invitation
to ﬁll out a number of questionnaires on, for example, lifestyle and medical
history, and to donate an 8.5 ml blood sample in a serum separator tube
and a 10 ml EDTA blood sample. The response to these questionnaires was
42% (N=9350). Of these responders, 69% (N=6468) also donated blood
samples. Our novel questionnaire was part of the second wave of NBS. In
this wave, 7986 individuals received an invitation, and the response rate to
our autistic traits questionnaire in the NBS sample was 70% (N= 5594).
After further evaluation of the data, we had complete questionnaire data
for 5066 NBS participants. Using the Promax method in SPSS 20.0 (SPSS
Technologies, Armonk, NY, USA), we then conducted a principal
component/factor analysis of the scores on the 18 individual questionnaire
items of all 5066 NBS participants, to ﬁnd out which combination of factors
(each consisting of the added scores from two or more individual items)
would explain the largest proportion of the observed variance in the total
score for ‘autistic traits in the general population’. Using SPSS 20.0 and the
answers of all 5066 NBS participants to the 18 questionnaire items, we also
determined the internal consistency (Crohnbach’s α) of the total autistic
traits score on our questionnaire.
Table 1. Customized self-report questionnaire of autistic traits in the general population
1 By looking at someone’s face, I ﬁnd it easy to work out what he or she is thinking or feeling (1)
2 I ﬁnd it hard to make new friends (1)a
3 I enjoy social occasions such as birthdays, receptions, and so on (1)
4 I can quickly work out whether someone is fascinated by what I say (1)
5 As a child, I was a late talker or I had other speech-related problems (2)a
6 I don’t know how to keep a conversation going (1)a
7 People tell me that I keep going on and on about the same thing (1)a
8 I ﬁnd making stories up easy (1)
9 I often get so absorbed in one thing that I lose sight of other things (1)a
10 It upsets me if my daily routine is disturbed (1)a
11 I prefer to do things the same way over and over again (1)a
12 I tend to notice details that others do not (1)a
13 As a child, I often retreated to my own world or I rarely played with other children (2)a
14 As a child, I moved in a rigid way or I tended to repeat certain movements (2)a
15 As a child, I often repeated the same words or I made up new words (2)a
16 As a child, I often took statements and jokes literally (2)a
17 As a child, I enjoyed playing games involving pretending with other children (1)
18 As a child, I frequently became upset by sudden and unexpected changes (2)a
The 18 questionnaire items were taken or derived from the AQ (designated with (1)) and the DSM-IV section about autism spectrum disorders (designated
with (2)). Abbreviations: AQ, Autism Spectrum Quotient; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. aReverse-scored item.
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Genome-wide association analysis
The factor analysis of the 18 individual questionnaire items revealed that a
combination of ﬁve factors explained the largest proportion of the
observed variance in the total autistic trait scores. Therefore, the total
autistic trait scores and scores for these ﬁve factors were corrected for age
and gender using information on 5066 NBS individuals. Residuals were
checked for independence, equal variance and normality and log or BLOM
transformation (SPSS Technologies) was applied. Residuals were saved and
used for each of the six phenotypes in the genome-wide association
analysis (the scores for ‘total autistic traits’ and its ﬁve constituting factors).
Genome-wide genotyping data was available for 1981 of the 5066 NBS
participants. For 1218 individuals, genotyping was performed using the
Human 370CNV Duo Beadchip (Illumina, San Diego, CA, USA). For 763
individuals, genotyping was performed using the Human OmniExpress
Beadchip (Illumina) (Supplementary Table 1). For all individuals, density of
genotype data was increased by imputation using 1000 genomes Phase I
version 3 as a reference and IMPUTE2 software (freely available by the
University of Oxford, UK).27
Genome-wide association analysis was carried out using SNPtest version
2.528 and performed separately for individuals genotyped on the two
platforms. Quality control was performed on imputation quality score
(info⩾ 0.6), minor allele frequency (⩾0.01) and Hardy–Weinberg equili-
brium (P⩾ 0.00001). Genome-wide results were combined in an inverse-
variance-weighted meta-analysis using METAL29 accounting for genomic
inﬂation. Final analysis included 8 610 357 autosomal single-nucleotide
polymorphisms (SNPs) across the genome. Subsequently, to ascertain the
extent of genetic and biological overlap between ASDs and autistic traits,
we used the summary statistics from the six independent GWASs for
shared genetic etiology and gene-set analyses.
Shared genetic etiology analysis
Applying the default settings of the polygenic risk score-based analysis
tool PRSice,30 we determined the level of shared genetic etiology between
ASDs and autistic traits, using the summary statistics data from a large
GWAS of ASDs by the Psychiatric Genomics Consortium (PGC) autism
group (PGC-ASD GWAS, data for 5305 ASD cases and 5305 controls—these
data are publicly available at: http://www.med.unc.edu/pgc/downloads)—
as 'base phenotype' sample and the summary statistics data from our six
independent GWAS meta-analyses of autistic traits (see above) as 'target
phenotype' samples. Before generating polygenic risk scores with PRSice
clumping was performed using PLINK, to select independent index SNPs
for each linkage disequilibrium (LD) block in the genome.31 The index SNPs
are selected based on signiﬁcance levels in the reference data set and form
clumps of all other SNPs that are within 500 kb and in LD (r240.25). Based
on the clumped summary statistics of the PGC-ASD GWAS, PRSice was then
used to generate polygenic risk scores for ASDs that are the sum of
genome-wide SNPs associated with ASDs weighted by their effect sizes
estimated from the PGC-ASD GWAS, from which only the SNPs exceeding
seven broad P-value thresholds (indicated by PT) were included, that is, the
SNPs with PTo0.001, 0.05, 0.1, 0.2, 0.3, 0.4 and 0.5. As such, seven genome-
wide polygenic scores were generated based on all SNPs that were
associated with the base ASD phenotype at Po0.001, 0.05, 0.1 and so on.
Subsequently, PRSice calculated P-values of shared genetic etiology—that
is, the extent to which the combined SNPs from each of the seven
PT-linked polygenic risk scores for ASD predict each of the six autistic trait
phenotypes—between the base ASD phenotype on the one hand and the
target phenotypes, that is, the total autistic traits score as well as the scores
for each of the ﬁve autistic trait factors, on the other hand. Last, the
calculated P-values of shared genetic etiology were aggregated and
corrected for multiple comparisons using the false discovery rate (FDR)
method, incorporating potential dependencies between P-values,32,33
similar to the approaches used in earlier studies working with multiple
traits and PRSice.34,35 To calculate the FDR, we used the mafdr function in
MATLAB (R2012a; The Mathworks) using the bootstrap selection method
for the FDR parameter lambda.
Gene-set analysis
We ﬁrst compiled gene sets containing all genes encoding proteins within
the three protein interaction networks that regulate steroidogenesis,
neurite outgrowth and (glutamatergic) synaptic function and that together
constitute our 'molecular landscape' of ASDs (Supplementary Table 2).10
For each gene from the three gene sets, all SNPs within exonic, intronic
and untranslated regions of the gene and within 100 kb downstream and
upstream of the gene were selected. The selection of the SNPs outside
each gene is based on the fact that the vast majority of expression quanti-
tative trait loci for a given gene are located within 100 kb downstream
and/or upstream of a gene36–38 and because trait-associated (GWAS) SNPs
are more likely to be expression quantitative trait loci.39
As our genome-wide association analysis only included autosomal SNPs,
12 genes located on the X chromosome (ARHGAP36, DACH2, DMD, GATA1,
JARID1C, MAMLD1, MSN, PLXNB3, RHFOX1, RHFOX2, SLC10A3, USP9X) were
omitted before the gene-set analysis. Gene-set analysis was then
performed using the Multimarker Analysis of GenoMic Annotation
(MAGMA) software package (http://ctglab.nl/software/magma).40 One of
the autosomal genes (MSNP1) was manually added to the genetic location
ﬁle of MAGMA to be able to include it in the analysis. The single SNP
P-values were transformed into a gene test-statistic by taking the mean of
the χ2 statistic among the SNPs in each gene. To account for LD, the 1000
Genomes Project European sample was used as a reference to estimate the
LD between SNPs within (the vicinity of) the genes (http://ctglab.nl/
software/MAGMA/ref_data/g1000_ceu.zip). Gene-wide P-values were con-
verted to z-values reﬂecting the strength of the association each gene has
with each of the six autistic traits phenotypes.
Subsequently, we tested whether the genes in each of the three gene
sets are jointly associated with each of the six autistic traits phenotypes.
Two tests were performed with MAGMA. The self-contained analysis tested
whether the gene set contains any association with the phenotype of
interest at all. This was carried out using an intercept-only linear regression
model including a subvector corresponding to the genes in the gene set,
and by evaluating whether the regression coefﬁcient of this regression was
40. The competitive analysis tested whether the difference between the
association of each gene set was different from the association of the
genes outside the gene set, taking into account the polygenic nature of
our traits. This was carried out by expanding the regression model to
include all annotated genes in the genome outside the gene set. To
account for the potentially confounding factors of gene size and gene
density, both gene size and gene density as well as their logarithms were
included as covariates in the competitive gene-set analysis. Considering
the polygenic nature of our trait, the competitive analyses have more
merit. Results were considered signiﬁcant if they exceeded a Bonferroni
correction threshold accounting for the number of gene sets and
phenotypes tested. The analysis was carried out in two steps. In step 1,
the combined effect of the SNPs in (the vicinity of) all genes on the total
autistic traits score as well as the scores for the ﬁve autistic trait factors was
analyzed. Post hoc, in step 2, the potential effects of the genes encoding
the proteins in the networks making up our molecular ASD landscape and
the individual gene(s) that may drive the association were investigated, by
reviewing their gene-test statistics. Genes were considered gene-wide
signiﬁcant if they reached the Bonferroni correction threshold adjusted for
the number of genes within the molecular ASD landscape.
RESULTS
Validation of the novel questionnaire of autistic traits in adults
The self-report questionnaire of autistic traits consisting of 18
items that we developed was applied to 50 healthy adults and 24
adults diagnosed with an ASD by an experienced psychiatrist.
Figure 1a shows the distribution of the scores for ‘total autistic
traits’ in both groups. As can be derived, the ASD-diagnosed
adults scored signiﬁcantly higher (Po0.001) than healthy adults
on the novel questionnaire.
In addition and as shown in Figure 1b, the correlation between
the total score on the new 18-item questionnaire and the total
score on the 50-item AQ was 0.703 (Po0.001). Furthermore, the
internal consistency of the total score on the new questionnaire
was satisfactory (Cronbach’s α= 0.70) and very similar to the
internal consistency of the total AQ score in the Dutch general
population (Cronbach’s α= 0.71).23
Measuring autistic traits in the Dutch general population and
factor analysis of the questionnaire scores
A total of 5066 adults from the NBS completed the questionnaire
(Supplementary Table 1). Supplementary Figure 1 shows that the
score for total autistic traits followed a normal distribution with a
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mean total score of 35.8 (s.d. = 6.5). Exploratory factor analysis of
the 18 individual questionnaire items revealed a ﬁve factors/
subscores solution as best-ﬁtting model to explain the variance in
the total score. We named these ﬁve factors ‘childhood behavior’,
‘rigidity’, ‘social skills’, ‘attention to detail’ and ‘imagination’. In
Table 2, the item content of and loadings on these ﬁve factors are
shown. Taken together, the ﬁve factors explained 50.7% of the
variance in the total autistic traits score.
Analysis of shared genetic etiology
In Supplementary Figures 2 and 3, the Manhattan and QQ plots of
the GWASs of the six autistic traits—that is, the scores for total
autistic traits and its ﬁve constituting factors are provided. We
found statistically signiﬁcant evidence for overlap between
genetic variants increasing the risk for ASDs derived from the
publicly available data set of the Psychiatric Genomics Consortium
(http://www.med.unc.edu/pgc/downloads) and genetic variants
associated with three autistic traits: ‘childhood behavior’
(FDR-corrected Po0.05), ‘rigidity’ (FDR-corrected Po0.05) and
‘attention to detail’ (FDR-corrected Po0.01). The most predictive
P-value thresholds (PT) were 0.001, 0.001 and 0.4, respectively
(Figure 2).
Gene-set analysis
According to the criteria described in the Materials and methods,
we selected the SNPs within (100 kb from) all autosomal genes
encoding proteins in the 'steroidogenesis', 'neurite outgrowth' and
'(glutamatergic) synaptic function' networks that we described
earlier based on published genetic studies of ASDs.10 The ﬁnal
data set for the gene-set analysis contained 147 unique genes and
231 002 SNPs (effective number of SNPs after adjusting for LD
structure = 79 993). MAGMA-based gene-set analysis38 revealed
Figure 1. Validation of the novel questionnaire of autistic traits in
adults. (a) Distributions of the total scores on the 18-item self-report
questionnaire (Q18 score) of autistic traits in a Dutch general
population sample of 50 adults* (General population (GP) partici-
pants, red line; total score range: 25–46; mean total score: 33
(s.d.= 5.4)) and in 24 adults with a conﬁrmed autism spectrum
disorder (ASD) diagnosis (ASD participants, blue line; total score
range: 37–66; mean total score: 50 (s.d.= 7.5)). ASD participants
scored signiﬁcantly higher than the GP participants (Po0.001; two-
sided T-test). (b) Correlation between Q18 score of autistic traits
(total score range: 25–46; mean total score: 33 (s.d.= 5.4)) and the
total scores on the 50-item AQ (Q50 score; total score range: 78–123;
mean total score: 98 (s.d.= 10.2)) in a Dutch GP sample of 50 adults*.
Each dot represents one participant. A signiﬁcant correlation
(correlation coefﬁcient R= 0.703; Po0.001) was observed between
the total autistic traits score on our 18-item questionnaire and the
total AQ score. *These are the same 50 respondents.
Table 2. Item content of and loadings on the ﬁve factors that constitute the best ﬁtting model to explain the variance in the total added score of the
18 items from our questionnaire of autistic traits that was completed by 5066 healthy adults from the NBS
Factor 1. Childhood behaviour (19.33% of the variance in the total score explained)
Items Factor loading
5.a As a child, I was a late talker or I had other speech-related problems 0.507
13.a As a child, I often retreated to my own world or I rarely played with other children 0.649
14.a As a child, I moved in a rigid way or I tended to repeat certain movements 0.712
15.a As a child, I often repeated the same words or I made up new words 0.654
16.a As a child, I often took statements and jokes literally 0.636
18.a As a child, I frequently became upset by sudden and unexpected changes 0.609
Factor 2. Rigidity (11.21% of the variance in the total score explained)
Items Factor loading
7.a People tell me that I keep going on and on about the same thing 0.447
9.a I often get so absorbed in one thing that I lose sight of other things 0.599
10.a It upsets me if my daily routine is disturbed 0.750
11.a I prefer to do things the same way over and over again 0.689
Factor 3. Social skills (7.49% of the variance in the total score explained)
Items Factor loading
2.a I ﬁnd it hard to make new friends 0.633
3. I enjoy social occasions such as birthdays, receptions, etc. 0.740
6.a I don’t know how to keep a conversation going 0.508
Factor 4. Attention to detail (6.89% of the variance in the total score explained)
Items Factor loading
1. By looking at someone’s face, I ﬁnd it easy to work out what he or she is thinking or
feeling
0.713
4. I can quickly work out whether someone is fascinated by what I say 0.743
12.a I tend to notice details that others do not − 0.521
Factor 5. Imagination (5.74% of the variance in the total score explained)
Items Factor loading
8. I ﬁnd making stories up easy 0.723
17. As a child, I enjoyed playing games involving pretending with other children 0.647
Taken together, the ﬁve factors explain 50.66% of the variance in the total score for autistic traits in the general population from our questionnaire.
Abbreviation: NBS, Nijmegen Biomedical Study. aA reverse-scored item.
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that 'rigidity' was signiﬁcantly associated with the complete set of
147 genes (Pself-contained = 0.036, Pcompetitive = 0.005). No signiﬁcant
association was found for the total autistic trait score or any of the
other four autistic trait factors (Table 3). Post hoc analysis of the
three networks individually showed that 'rigidity' was associated
with neurite outgrowth (Pself-contained = 0.035, Pcompetitive = 0.003),
while the gene-set associations for the networks regulating
steroidogenesis and (glutamatergic) synaptic function were both
nonsigniﬁcant (Table 3). Within the neurite outgrowth gene-set,
gene-wide association of ‘rigidity’ with the MET gene was
signiﬁcant after correction for multiple testing (P= 0.000143), see
Supplementary Figure 4.
DISCUSSION
In this study, we developed a short self-report questionnaire for
the assessment of current and childhood behaviors relevant to
ASDs in the adult general population, which is based on the
longer AQ instrument and the Diagnostic and Statistical Manual of
Mental Disorders, 4th Edition criteria for the diagnosis of ASDs. We
described the successful validation of the questionnaire. After
assessment of over 5000 individuals, we performed GWASs of the
total questionnaire score and the subscores for ﬁve autistic traits
derived through factor analysis in 1981 individuals, for whom
genome-wide genotyping data was available. We subsequently
used the summary statistics of the PGC-ASD GWAS to determine
the genetic overlap between ASDs and autistic traits. We indeed
found signiﬁcant evidence for a shared genetic etiology between
ASDs and three autistic traits, 'childhood behavior', 'rigidity' and
'attention to detail'.
Furthermore, gene-set analysis revealed a signiﬁcant association
of ‘rigidity’ with ASD-implicated genes encoding proteins inter-
acting within a molecular network regulating neurite outgrowth.
Among the neurite outgrowth-linked genes, the MET gene
showed signiﬁcant gene-wide association with the ‘rigidity’ trait.
As rigidity is an overlapping trait of several neurodevelopmental
disorders, the neurite outgrowth gene set and the MET gene could
be further studied as candidates for other psychiatric disorders
such as obsessive–compulsive disorder (OCD).
Figure 2. Bar plots from PRSice30 showing results at seven broad P-value thresholds (PT) for shared genetic etiology between autism spectrum
disorders (ASDs) and the six autistic trait phenotypes (a–f) (see Materials and methods). The numbers above the bars indicate the P-values for
shared genetic etiology, and these P-values were corrected using the false discovery rate (FDR) method. *FDR-corrected Po0.05, **FDR-
corrected Po0.01. SNP, single-nucleotide polymorphism.
Table 3. Association results from the autistic traits gene-set analyses
with the combined gene sets are shown at the top
PSelf-contained PCompetitive
Autistic trait
Total score 0.592 0.214
Childhood behavior 0.847 0.891
Rigidity 0.036 0.005
Social skills 0.799 0.506
Attention to detail 0.996 0.680
Imagination 0.657 0.602
Gene set
Steroidogenesis (21 genes) 0.076 0.065
Neurite outgrowth (103 genes) 0.034 0.003
(Glutamatergic) synaptic function (43
genes)
0.234 0.599
Results of the post hoc separate analyses for the three protein interaction
networks for the rigidity trait are shown below. Signiﬁcant P-values
(o0.05) are in bold.
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A number of questionnaires for autistic traits in the general
population haven been developed, and of those, the AQ and the
SCDC are commonly used in genetic studies. The AQ is a 50-item
self-report questionnaire of autistic traits in adults,22,23 the SCDC is
a parent-rated questionnaire measuring social communication
impairment in children.24,25 Compared with the SCDC, our
questionnaire has the advantage of capturing more domains
relevant to autistic behavior than only social communication
impairment. Advantages compared with the AQ are the brevity of
the questionnaire—which makes it more readily applicable in
large population studies—and the fact that its factor structure was
derived in a data-driven, unbiased approach, whereas the AQ was
built around ﬁve predeﬁned, theory-based factors or subgroups of
10 questions each. The new questionnaire showed construct
validity, reﬂected by a moderately high internal consistency of the
total score of the responses to the 18 questions. In addition, it was
shown to have a high discriminant validity, that is, the ability to
differentiate between people with less and more autistic traits, the
latter including those with a clinical ASD diagnosis. Similar to the
AQ,22,23 the total score on our questionnaire also followed a
normal distribution.
Although over 5000 adults completed the questionnaire,
genome-wide genotyping was only available for 1981 persons.
This sample size did not lend itself to the evaluation of association
results for individual genetic variants, but provided sufﬁcient
power for genetic overlap analysis with the large PGC GWAS
of ASDs.
Our ﬁndings of genetic sharing between ASDs and the
population traits ‘childhood behavior’, ‘rigidity’ and ‘attention to
detail’ add further weight to previous reports, suggesting that the
same genetic susceptibility factors underlie both ASDs and autistic
traits.13,18
Importantly, as exclusively social and communication impair-
ments have been investigated thus far,19,25 our results extend this
concept of genetic sharing to also include traits linked to
repetitive and stereotyped patterns of behavior, interests and
activities observed in people with ASDs.
As shown in Figure 2, the shared genetic etiology analysis
provided estimates for the proportion of the variance in autistic
traits explained by common genetic variants associated with
ASDs, and the highest proportions of variance explained (reaching
signiﬁcance) were 0.17% for ‘childhood behavior’, 0.24% for
‘rigidity’ and 0.54% for ‘attention to detail’. Although these
proportions may seem quite small, they are similar to the
percentages found in other studies that used polygenic risk
scoring for neuropsychiatric disorders and quantitative traits. For
instance, the polygenic risk derived from an attention-deﬁcit
hyperactivity disorder GWAS meta-analysis explained 0.10% of the
phenotypic variance observed in an independent attention-deﬁcit
hyperactivity disorder sample,41 the polygenic risk associated with
educational attainment explained 0.60% of the observed variance
in adolescents' behavioral problems42 and the polygenic risk
derived from a GWAS of OCD explained 0.20% of the observed
variance in OCD-like symptoms in a population-based twin-family
sample.43 Last, although the explained variances of polygenic risk
scores are small, quantile analyses showed associations between
risk scores and behavior by septiles, highlighting the potential to
stratify individuals based on polygenic risk scores.42 In light of the
above, the observed variance explained in the three autistic traits
is likely an underestimate as the identiﬁed percentage of
explained variance is dependent on the size of the 'base
phenotype' sample for the generation of the polygenetic risk
scores.44
In addition to the shared genetic etiology analysis, the available
sample size lent itself to gene-set analysis, in which we tested the
combined effect of common variants within (the vicinity of) all
genes from a certain gene set. Considering multiple genetic
variants within the same analysis likely increases the explained
phenotypic variance, thereby boosting the power of genetic
studies.45–47 Our results point toward the biological process of
neurite outgrowth being implicated in both ASDs10 and the
‘rigidity’ trait, which yields evidence of a direct biological link
between ASDs and a speciﬁc autistic trait. However, neurite
outgrowth is not uniquely linked to ASDs and autistic traits, and
genetic variance in neurite outgrowth-related genes has also been
shown to be relevant to, for example, attention-deﬁcit hyper-
activity disorder,47,48 OCD49,50 and schizophrenia.51,52 This reﬂects
genetic overlap between clinically related disorders53,54 and
highlights the potential of studying traits that are shared between
disorders—such as ‘rigidity’—for psychiatric genetic research.
One gene within the ‘neurite outgrowth’ gene set, MET, reached
gene-wide evidence of association with ‘rigidity’ in our study.
MET is a well-established ASD gene and its involvement in
disease etiology has been implicated through multiple lines of
evidence, including both common and rare genetic variants,
gene expression studies and brain connectivity studies.55 Apart
from the already established role of the MET-encoded protein in
the ‘neurite outgrowth’ and ‘steroidogenesis’ networks (and
hence the presence of MET in the corresponding gene sets)
that form a part of our ‘molecular landscape’ of ASDs (see
above),10 a recent study shows that the MET protein is also an
important regulator of glutamatergic synapse development and
maturation.56
The fact that both the ‘neurite outgrowth’ gene set and the
established ASD gene MET are associated with a speciﬁc autistic
trait in a general adult population sample provides a proof of
concept for the potential of autistic trait studies in the search for
novel ASD susceptibility genes and for the potential translatability
of genetic ﬁndings from childhood to adulthood.
Our study should be viewed in the context of some strengths
and limitations. The new and fast self-report questionnaire that we
developed has the advantage that a large number of individuals
can be assessed in a relatively cheap way. Although self-report
data suffer from a number of limitations—such as reporter bias
and misinterpretation of the questionnaire items by the respon-
dents—we minimized these biases by validating our question-
naire in both a general population and an ASD sample and
comparing it to the already well-established AQ.22,23 The sample
size of the GWASs that we conducted was too small for
discovering new single genetic variant associations, but it was
large enough to provide proof of concept—through shared
genetic etiology and gene-set/gene-wide analyses—for sharing
beyond social communication traits. Analyses of autistic traits
using larger population samples can be expected to lead to the
discovery of novel ASD-relevant genes, which will increase our
understanding of the (altered) biology underlying ASDs. Our
approach shows great potential for other psychiatric disorders
that could beneﬁt from being genetically dissected with a similar
approach.
In conclusion, our ﬁndings of genetic sharing between ASDs
and autistic traits, and of gene-set-based and gene-wide associa-
tion of ASD-implicated genes with the autistic trait rigidity,
provide evidence for a shared genetic and biological etiology
underlying ASDs and autistic population traits, beyond earlier
described social communication traits.
As (existing) population-based cohorts could be used in trait
genetic studies, this could offer tremendous opportunities to our
ﬁeld, as we can increase our sample sizes considerably at relatively
little cost.
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